171: ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC).
Authors
Lawless, CLandau, D
Faivre-Finn, Corinne
Boyd, K
Lester, J
Fenwick, J
Maguire, J
Mccartney, E
Paul, J
Parsons, E
Peek, A
Haswell, T
Hatton, M
Affiliation
CRUK Clinical Trials Unit Glasgow, NHS Greater Glasgow & Clyde,GlasgowIssue Date
2017-01
Metadata
Show full item recordCitation
171: ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). 2017, 103(suppl 1):S80-S81 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(17)30221-0Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500217302210Type
Meetings and ProceedingsLanguage
enISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(17)30221-0